
Aurobindo Pharma closing in on $5.5b Zentiva buyout
Mumbai: Aurobindo Pharma has emerged as the frontrunner to acquire Prague-based generic drugmaker Zentiva for $5-5.5 billion (Rs 43,500-47,900 crore) from Advent International, said several people aware of the matter, underscoring the growing consolidation …